Literature DB >> 2840167

The physiological relevance of low agonist affinity binding at opioid mu-receptors.

J A Carroll1, J S Shaw, A D Wickenden.   

Abstract

1. Inhibition constant (Ki) were determined for a range of opioid standards using two binding assays; [3H]-[D-Ala2, MePhe4, Gly-ol5]enkephalin ([3H]-GLYOL) binding to guinea-pig brain membranes in HEPES buffer and [3H]-naloxone binding to rat whole brain membranes in Krebs/HEPES buffer. 2. These values were compared with affinity measurements determined by antagonism of GLYOL on the rat isolated vas deferens preparation and by the receptor occlusion technique of Furchgott on the guinea-pig ileum longitudinal muscle, myenteric plexus preparation. 3. Agonists demonstrated markedly reduced binding affinity in the [3H]-naloxone binding assay where binding was conducted in the presence of sodium. 4. A strong correlation was obtained between Ki values from the [3H]-naloxone binding assay and affinity values determined in both isolated tissue preparations. Ki values obtained from [3H]-GLYOL binding did not correlate well with affinity data determined by isolated tissue techniques. 5. These findings suggest that functionally relevant receptors exhibit low agonist affinity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840167      PMCID: PMC1854000          DOI: 10.1111/j.1476-5381.1988.tb11569.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides.

Authors:  K J Chang; B R Cooper; E Hazum; P Cuatrecasas
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

2.  Receptor binding and pharmacological activity of opiates in the guinea-pig intestine.

Authors:  I Creese; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1975-07       Impact factor: 4.030

3.  Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect.

Authors:  E J Simon; J M Hiller; J Groth; I Edelman
Journal:  J Pharmacol Exp Ther       Date:  1975-03       Impact factor: 4.030

4.  Interaction of ligands with the opiate receptors of brain membranes: regulation by ions and nucleotides.

Authors:  A J Blume
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

5.  Receptor affinity and pharmacological potency of a series of narcotic analgesic, anti-diarrheal and neuroleptic drugs.

Authors:  K D Stahl; W van Bever; P Janssen; E J Simon
Journal:  Eur J Pharmacol       Date:  1977-12-01       Impact factor: 4.432

6.  Opiate agonists and antagonists discriminated by receptor binding in brain.

Authors:  C B Pert; G Pasternak; S H Snyder
Journal:  Science       Date:  1973-12-28       Impact factor: 47.728

7.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

8.  Properties of opiate-receptor binding in rat brain.

Authors:  C B Pert; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

9.  Mu-receptor binding in physiological media: comparison with isolated tissue data.

Authors:  J A Carroll; L Miller; J S Shaw; C P Downes
Journal:  Neuropeptides       Date:  1984-12       Impact factor: 3.286

10.  The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips.

Authors:  W D Paton; M A Zar
Journal:  J Physiol       Date:  1968-01       Impact factor: 5.182

View more
  7 in total

1.  Disruption of the Na+ ion binding site as a mechanism for positive allosteric modulation of the mu-opioid receptor.

Authors:  Kathryn E Livingston; John R Traynor
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

Review 2.  The role of δ-opioid receptors in learning and memory underlying the development of addiction.

Authors:  Paul Klenowski; Michael Morgan; Selena E Bartlett
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

3.  ICI 204448: a kappa-opioid agonist with limited access to the CNS.

Authors:  J S Shaw; J A Carroll; P Alcock; B G Main
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

4.  Selective changes in mu opioid receptor properties induced by chronic morphine exposure.

Authors:  L L Werling; P N McMahon; B M Cox
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure.

Authors:  William T Birdsong; Seksiri Arttamangkul; Mary J Clark; Kejun Cheng; Kenner C Rice; John R Traynor; John T Williams
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

6.  Alkylation with beta-funaltrexamine suggests differences between mu-opioid receptor systems in guinea-pig brain and myenteric-plexus.

Authors:  T G Franklin; J R Traynor
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

7.  Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level.

Authors:  Ronald B Moss; Meghan McCabe Pryor; Rebecca Baillie; Katherine Kudrycki; Christina Friedrich; Mike Reed; Dennis J Carlo
Journal:  PLoS One       Date:  2020-06-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.